Easing the burden: exploring the role of long-acting testosterone formulations in gender-affirming care

IntroductionLong-acting testosterone formulations are essential but infrequently used for gender affirmation. Although not FDA approved in the United States for gender dysphoria, testosterone undecanoate is a long-acting testosterone formulation administered every 10 weeks. Similarly, Testopel is an...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rahil Hudda, Vi Nguyen, Ravi Iyengar, Allan Pfeil, T. Mike Hsieh, Jill Blumenthal
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-02-01
coleção:	Frontiers in Public Health
Assuntos:	gender dysphoria gender-affirming care hormone replacement therapy injectable long-acting testosterone
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fpubh.2026.1751013/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!